Alpha	O
-	O
melanocyte	O
-	O
stimulating	O
hormone	O
modulates	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
and	O
AP	O
-	O
1	O
and	O
secretion	O
of	O
interleukin	O
-	O
8	O
in	O
human	O
dermal	B-Cell
fibroblasts	I-Cell
.	O

Alpha	O
-	O
melanocyte	O
-	O
stimulating	O
hormone	O
(	O
alpha	O
-	O
MSH	O
)	O
has	O
evolved	O
as	O
a	O
mediator	O
of	O
diverse	O
biological	O
activities	O
in	O
an	O
ever	O
-	O
growing	O
number	O
of	O
non	B-Cell
-	I-Cell
melanocytic	I-Cell
cell	I-Cell
types	O
.	O

One	O
mechanism	O
by	O
which	O
alpha	O
-	O
MSH	O
exerts	O
its	O
effects	O
is	O
modulation	O
of	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappa	O
B	O
.	O

These	O
two	O
transcription	O
factors	O
also	O
play	O
an	O
important	O
role	O
in	O
fibroblasts	B-Cell
,	O
in	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
composition	O
,	O
and	O
in	O
cytokine	O
expression	O
.	O

By	O
use	O
of	O
electric	O
mobility	O
shift	O
assays	O
,	O
we	O
demonstrate	O
that	O
alpha	O
-	O
MSH	O
(	O
10	O
(	O
-	O
6	O
)	O
to	O
10	O
(	O
-	O
14	O
)	O
M	O
)	O
activates	O
AP	O
-	O
1	O
in	O
human	O
dermal	B-Cell
fibroblasts	I-Cell
,	O
whereas	O
coincubation	O
with	O
interleukin	O
-	O
1	O
beta	O
(	O
IL	O
-	O
1	O
beta	O
)	O
results	O
in	O
suppression	O
of	O
its	O
activation	O
.	O

alpha	O
-	O
MSH	O
also	O
induces	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
but	O
does	O
not	O
modulate	O
DNA	O
binding	O
on	O
costimulation	O
with	O
IL	O
-	O
1	O
beta	O
.	O

Since	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappa	O
B	O
are	O
key	O
elements	O
in	O
controlling	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
transcription	O
,	O
human	O
fibroblasts	B-Cell
were	O
treated	O
with	O
alpha	O
-	O
MSH	O
and	O
IL	O
-	O
1	O
beta	O
for	O
24	O
hours	O
,	O
and	O
cytokine	O
levels	O
in	O
the	O
supernatants	B-Organism_substance
were	O
measured	O
by	O
ELISA	O
.	O

alpha	O
-	O
MSH	O
alone	O
had	O
little	O
effect	O
,	O
whereas	O
coincubation	O
with	O
IL	O
-	O
1	O
beta	O
led	O
to	O
marked	O
downregulation	O
of	O
IL	O
-	O
8	O
secretion	O
(	O
at	O
most	O
288	O
+	O
/	O
-	O
152	O
ng	O
/	O
mL	O
)	O
when	O
compared	O
to	O
treatment	O
with	O
IL	O
-	O
1	O
beta	O
alone	O
(	O
919	O
+	O
/	O
-	O
157	O
ng	O
/	O
mL	O
)	O
.	O

Our	O
results	O
indicate	O
that	O
alpha	O
-	O
MSH	O
exerts	O
modulatory	O
effects	O
on	O
the	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
and	O
AP	O
-	O
1	O
,	O
and	O
that	O
it	O
can	O
regulate	O
chemokine	O
secretion	O
in	O
human	O
dermal	B-Cell
fibroblasts	I-Cell
.	O

These	O
effects	O
of	O
alpha	O
-	O
MSH	O
may	O
have	O
important	O
regulatory	O
functions	O
in	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
composition	O
,	O
wound	B-Pathological_formation
healing	O
,	O
or	O
angiogenesis	O
.	O

